Biomind Labs announces positive results of Phase 2 clinical trial of BMND08 for depression & anxiety in Alzheimer’s disease
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
Nu Nutridac is a nutritional replenisher for neurodegenerative and anxiety-related disorders
Phesgo label expansion delivers on patients’ preference for at-home administration and is an important step in freeing up cancer care capacity in clinical settings
Sensory Boxes include items such as drawing boards and fidget balls to support management of anxiety and improve shopping experience
Dr. Prabhavathi brings over 14 years of unparalleled experience in pediatrics and a specialized focus on neurodevelopmental disorders
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
The company will also share results in two additional posters for deuruxolitinib
The built-in AI-trained algorithms will empower users to proactively intervene when their glucose levels require attention and before a complication can even occur
Receives 3 final and 2 tentative product approvals thus far in Q1FY25
Subscribe To Our Newsletter & Stay Updated